Pfizer Inc. and Pharmacia Corporation

Last Updated:
In the Matter of Pfizer Inc. and Pharmacia Corporation
FTC Matter/File Number:

021 0192

Docket Number:

C-4075

Enforcement Type:

Part 2 Consents

Case Summary

A final consent order permits Pfizer Inc.'s acquisition of Phamacia Corporation while requiring the divestiture of various products including extended release drugs used in the treatment of an overactive bladder; hormone replacement therapies; erectile dysfunction; canine arthritis; and motion sickness. Novartis AG, Neurocrine Biosciences, Inc., Schering-Plough Corporation, Johnson & Johnson, Insight Pharmaceuticals Corporation, and Cadbury Schweppes are named in the order as potential buyers of the various pharmaceuticals and products.